Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
43.89 USD | +3.37% | +9.15% | -8.22% |
Jun. 14 | Wedbush Adjusts Ultragenyx Pharmaceutical's Price Target to $45 From $48, Keeps Neutral Rating | MT |
Jun. 14 | Sector Update: Health Care Stocks Lean Lower Pre-Bell Friday | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.22% | 3.97B | |
+20.95% | 127B | |
+23.00% | 117B | |
+26.20% | 27.77B | |
-19.75% | 20.44B | |
-14.97% | 16.62B | |
-16.56% | 15.92B | |
+11.19% | 14.74B | |
-46.65% | 14.94B | |
+57.74% | 14.38B |
- Stock Market
- Equities
- RARE Stock
- News Ultragenyx Pharmaceutical Inc.
- Transcript : Ultragenyx Pharmaceutical Inc. - Special Call